Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz - Terri D’Arrigo (Psychiatric News, 2023)

The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study - Brain; Cognition Discovery Foundation (ClinicalTrials.gov, 2023)

“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance - Finkelstein C; Soha O; Roy A; Phillipou A; Rossell S. (Research Square, 2023)

An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients. - The Roots to Thrive Society for Psychedelic Therapy (ClinicalTrials.gov, 2023)

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial. - Husain MI; Blumberger DM; Castle DJ; Ledwos N; Fellows E; Jones BDM; Ortiz A; Kloiber S; Wang W; Rosenblat JD; Mulsant BH (BJPsych open, 2023)

Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change? - Rudzki S (Military medicine, 2023)

Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract - Shahar O; Botvinnik A; Shwartz A; Lerer E; Buko A; Hamid E; Kahn D; Guralnick M; Blakolmer K; Wolf G; Lerer L; Lerer B; et al. (Research Square, 2023)

Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression - Goodwin G; Marwood L; Mistry S; Nowakowska A; Simmons H; Tsai J; Williams S; Young M; Malievskaia E. (European psychiatry: the journal of the Association of European Psychiatrists, 2023)

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol - Husain M; Blumberger D; Castle D; Kloiber S; Ortiz A; Rosenblat J; Mulsant B. (European psychiatry: the journal of the Association of European Psychiatrists, 2023)

Psychedelics for depression: from neurobiology to treatment - Kuypers K. (European psychiatry: the journal of the Association of European Psychiatrists, 2023)

Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment - Sousa R; Costa L; Brás J; Vaz R; Martins J; Abreu J; Almeida E; Castro N; Andrade R; Cunha N. (European psychiatry: the journal of the Association of European Psychiatrists, 2023)

The therapeutic potential of psilocybin in depression resistant to psychotropic drugs - Ramírez González J; Fernández Márquez I; Ferreiro González S; Ruíz E. (European psychiatry: the journal of the Association of European Psychiatrists, 2023)

A systematic review to assess the use of psilocybin in the treatment of headaches - Bhanot S; Lin M; Bains S; Monroe A; Tsang V. (European psychiatry: the journal of the Association of European Psychiatrists, 2023)

Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression - Lin M; Lee H; Tsang V; Chai B; Howard A; Uy C; Elefante J. (European psychiatry: the journal of the Association of European Psychiatrists, 2023)

Psilocybin as an antidepressant strategy - a review of safety aspects - Zeiss R. (European psychiatry: the journal of the Association of European Psychiatrists, 2023)

Pharmacognostic, Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Multidisciplinary Study with an Assessment of Peculiarities of Circulation (Use) of Smoking Mixtures of Spices and Entheogens of Amanita Muscaria Mushroom - Вікторія Шаповалова; Alina Osyntseva; Валерій Шаповалов; Serhii Nehretskii (SSP Modern Pharmacy and Medicine, 2023)

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions - William Brennan; Alex Kelman; Alexander B. Belser (PsyArXiv, 2023)

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions - Brennan B; Kelman A; Belser AB. (PsyArXiv, 2023)

Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour - Nkadimeng SM; Hay L; Steinmann CM; Eloff JN. (Research Square, 2023)

Psilocybin Therapy for Major Depressive Disorder: A Systematic Review - Venugopal Kaden L. (Undergraduate Research in Natural and Clinical Science and Technology Journal, 2023)

Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings - Nicolas Garel; Julien Thibault Lévesque; Dasha A. Sandra; Justin Lessard-Wajcer; Elizaveta Solomonova; Michael Lifshitz; Stéphane Richard-Devantoy; Kyle T. Greenway (Frontiers in Human Neuroscience, 2023)

Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review - Jorge Valdiviezo-Oña; Lizbeth Toscano-Molina; Juan Fernando Chávez; Jonathan Elias Herrera Criollo; Clara Paz (Advances in Mental Health, 2023)

Confronting the figure of the “mad scientist” in psychedelic history: LSD’s use as a correctional tool in the postwar period - A. Jones (Frontiers in Psychology, 2023)

Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics. - Nogrady B (BMJ (Clinical research ed.), 2023)

Leveraging psychedelic therapies for binge eating disorder - Jim Gilligan (Open Access Government, 2023)

[Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models]. - Chernoff T; Kliger B; Venturini DH (Vertex (Buenos Aires, Argentina), 2023)

Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice. - Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maede K; González-Maeso J; Kitagaki S; et al. (Research square, 2023)

Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin - Tetem J; Fischmann T; Möller TJ. (PsyArXiv, 2023)

Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD) - Cybin Therapeutics Inc. (ClinicalTrials.gov, 2023)

Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin - Jenny Tetem; Tamara Fischmann; Tim Julian Möller (PsyArXiv, 2023)

Introduction to the chemistry and pharmacology of psychedelic drugs - Scott R. Walker; Glenn A. Pullella; Matthew Piggott; Peter J. Duggan (Australian Journal of Chemistry, 2023)

Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effects - McCulloch DE; Olsen AS; Ozenne B; Stenbaek DS; Armand S; Madsen MK; Knudsen GM; Fisher PM. (medRxiv, 2023)

Psychedelic drug psilocybin shows promise treating anorexia in early trials - Grace Wade (The New Scientist, 2023)

Trip Where you Stand: Towards Psychedelic Liberation - Kiara Mohamed Amin; Priya Sharma (Feminist Review, 2023)

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020. - Kopra EI; Ferris JA; Winstock AR; Kuypers KP; Young AH; Rucker JJ (Journal of psychopharmacology (Oxford, England), 2023)

Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial. - Sloshower J; Skosnik PD; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC (Journal of psychopharmacology (Oxford, England), 2023)

The need for establishing best practices and gold standards in psychedelic medicine. - Feduccia A; Agin-Liebes G; Price CM; Grinsell N; Paradise S; Rabin DM (Journal of affective disorders, 2023)

The molecular basis of the antidepressant action of the magic mushroom extract, psilocin - Hakami Zanjani Ali Asghar; Nguyen Teresa Quynh Tram; Jacobsen Luise; Khandelia Himanshu (Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2023)

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression. - Weiss B; Erritzoe D; Giribaldi B; Nutt DJ; Carhart-Harris RL (Journal of psychopharmacology (Oxford, England), 2023)

Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder? - Rossell SL; Meikle SE; Williams ML; Castle DJ (The Australian and New Zealand journal of psychiatry, 2023)

Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434. - Gaddis A; Lidstone DE; Nebel MB; Griffiths RR; Mostofsky SH; Mejia AF; Barrett FS (NeuroImage, 2023)

The down-scheduling of MDMA and psilocybin(e): Too fast and too soon. - Kisely S (The Australian and New Zealand journal of psychiatry, 2023)

New Pharmacologic Approaches to the Treatment of Bipolar Depression. - Keramatian K; Chakrabarty T; DuBow A; Saraf G; Yatham LN (Drugs, 2023)

Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories. - Benvenuti F; Colombo D; Soverchia L; Cannella N; Domi E; Ciccocioppo R (Psychopharmacology, 2023)

Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use. - Gukasyan N; Griffiths RR; Yaden DB; Antoine DG; Nayak SM (Journal of psychopharmacology (Oxford, England), 2023)

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first. - Haridy R (Nature, 2023)

Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms. - Skosnik PD; Sloshower J; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC (Journal of psychopharmacology (Oxford, England), 2023)

Psilocybin's effects on cognition and creativity: A scoping review. - Bonnieux JN; VanderZwaag B; Premji Z; Garcia-Romeu A; Garcia-Barrera MA (Journal of psychopharmacology (Oxford, England), 2023)

Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review. - Hovmand OR; Poulsen ED; Arnfred S; Storebø OJ (Journal of psychopharmacology (Oxford, England), 2023)

FDA issues first draft guidance on psychedelic research - Valerie A. Canady (Mental Health Weekly, 2023)

Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study - Gwyther M; Aspell JE. (PsyArXiv, 2023)

Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study - Matt Gwyther; Jane E Aspell (PsyArXiv, 2023)

Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives. - Jachimowski A; Kucia K (Psychiatria polska, 2023)

Daily briefing: Australia will be first to prescribe these psychedelics as medicines - Flora Graham (Nature, 2023)

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder - Halucenex Life Sciences Inc. (ClinicalTrials.gov, 2023)

Experts Offer Tips on Talking With Patients About Psychedelics - Terri D’Arrigo (Psychiatric News, 2023)

Psychedelic Therapy Requires Enhanced Consent Discussions - Nick Zagorski (Psychiatric News, 2023)

Psilocybin decelerates cellular senescence - Hecker L; kato k; Kleinhenz JMK; Shin Y; Papageorgiou J; Zarrabi A. (Research Square, 2023)

Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation. - Cheung K; Patch K; Earp BD; Yaden DB (Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees, 2023)

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats - Tylš Filip; Vejmola Čestmír; Koudelka Vlastimil; Piorecká Václava; Kadeřábek Lukáš; Bochin Marcel; Novák Tomáš; Kuchař Martin; Bendová Zdeňka; Brunovský Martin; Horáček Jiří; Pálení ček Tomáš (Frontiers in Neuroscience, 2023)

In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape. - Luppi AI; Hansen JY; Adapa R; Carhart-Harris RL; Roseman L; Timmermann C; Golkowski D; Ranft A; Ilg R; Jordan D; Bonhomme V; Vanhaudenhuyse A; et al. (Science advances, 2023)

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders. - Wulff AB; Nichols CD; Thompson SM (Neuropharmacology, 2023)

Psychedelics reopen the social reward learning critical period - Romain Nardou; Edward J. Sawyer; Young Jun Song; M. F. Wilkinson; Yasmin Padovan-Hernandez; Júnia L. de Deus; Noelle Wright; Carine Lama; Sehr Faltin; Loyal A. Goff; Genevieve Stein-O’Brien; Gül Dölen (Nature, 2023)

A regulatory framework review of Schedule I psychedelics in the United States - Kevin Herkenham (JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2023)

The treatment of abandonment anxiety with MDMA and LSD - Turkia M. (PsyArXiv, 2023)

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study - Nayak SM; White S; Hilbert S; Lowe MX; Jackson H; Griffiths RR; Garcia-Romeu A; Yaden DB. (PsyArXiv, 2023)

Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study - Turkia M. (PsyArXiv, 2023)

The treatment of abandonment anxiety with MDMA and LSD - Mika Turkia (PsyArXiv, 2023)

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study - Nayak SM; White SH; Hilbert S; Lowe MX; Jackson H; Griffiths RR; Garcia-Romeu A; Yaden DB. (PsyArXiv, 2023)

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study - Sandeep M Nayak; Sydney White; Samantha Hilbert; Matthew X Lowe; Heather Jackson; Roland R. Griffiths; Albert Garcia-Romeu; David Bryce Yaden (PsyArXiv, 2023)

Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study - Mika Turkia (PsyArXiv, 2023)

No trip needed for psychedelics to lift mood? - O'Grady C (Science (New York, N.Y.), 2023)

Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders. - Kargbo RB (ACS medicinal chemistry letters, 2023)

Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes - Nkadimeng SM; Steinmann CM; Eloff JN. (Preprints.org, 2023)

The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness - Schmidt TT; Costines C; Tagliazucchi E; Millière R; Garrido JM; Cuiule JI. (PsyArXiv, 2023)

Is Microdosing a Placebo? - Polito V; Liknaitzky P. (PsyArXiv, 2023)

The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness - Timo Torsten Schmidt; Cyril Costines; Enzo Tagliazucchi; Raphaël Millière; Juan Manuel Garrido; Juan Ignacio Cuiule (PsyArXiv, 2023)

Is Microdosing a Placebo? - Vince Polito; Paul Liknaitzky (PsyArXiv, 2023)

Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression - Wall MB; Demetriou L; Giribaldi B; Roseman L; Ertl N; Erritzoe D; Nutt DJ; Carhart-Harris RL. (medRxiv, 2023)

Psilocybin therapy: A novel approach to treating depression - Tooba Noor; Areej Shakil; Aimen Waqar Khan; Syeda Mahrukh Fatima Zaidi; Hussain Sohail Rangwala; Burhanuddin Sohail Rangwala (International Journal of Surgery Global Health, 2023)

Psilocybin (Magic Mushrooms) - N. Jiten Singh (GFNPSS-International Journal of Multidisciplinary Research, 2023)

ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study Design - Basant Pradhan; Ankit Rana; Edward Goldschmidt; Anthony L. Rostain (Neuromodulation Technology at the Neural Interface, 2023)

Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review - Halman A; Kong G; Sarris J; Perkins D. (medRxiv, 2023)

National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities. - Xi D; Berger A; Shurtleff D; Zia FZ; Belouin S (Neuropharmacology, 2023)

In silico characterization of the psilocybin biosynthesis pathway. - Irvine W; Tyler M; Delgoda R (Computational biology and chemistry, 2023)

Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder. - Agrawal M; Emanuel E; Richards B; Richards W; Roddy K; Thambi P (JAMA oncology, 2023)

Role of Psychedelics in Treatment-Resistant Depression. - Kamal S; Jha MK; Radhakrishnan R (The Psychiatric clinics of North America, 2023)

The evolution and ecology of psilocybin in nature. - Meyer M; Slot J (Fungal genetics and biology: FG & B, 2023)

Global species diversity and distribution of the psychedelic fungal genus. - Strauss D; Ghosh S; Murray Z; Gryzenhout M (Heliyon, 2023)

Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. - Moliner R; Girych M; Brunello CA; Kovaleva V; Biojone C; Enkavi G; Antenucci L; Kot EF; Goncharuk SA; Kaurinkoski K; Kuutti M; Fred SM; et al. (Nature neuroscience, 2023)

The Perilous Policy of Oregon's Psilocybin Services. - Holoyda B (The journal of the American Academy of Psychiatry and the Law, 2023)

The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs. - Lake S; Lucas P (Psychedelic medicine (New Rochelle, N.Y.), 2023)

Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress. - Gold ND; Podrebarac SK; White LA; Marini C; Simon NM; Mittelman MS; Ross S; Bogenschutz MP; Petridis PD (Psychedelic medicine (New Rochelle, N.Y.), 2023)

Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD). - Manish Agrawal; Sarah Shnayder; Heather Honstein; Ezekiel Emanuel; Paul Thambi (Journal of Clinical Oncology, 2023)

Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism - Whelan TP; Daly E; Puts NA; Malievskaia E; Murphy DG; McAlonan GM. (medRxiv, 2023)

Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans - Combat Stress (ClinicalTrials.gov, 2023)

Neurobiological Correlates of Psilocybin Response in Depression. - Qasim S; Zaheer Z; Jawad MY; Shad MU (The primary care companion for CNS disorders, 2023)

Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers - University of Wisconsin; Madison (ClinicalTrials.gov, 2023)

TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology. - Ort A; Smallridge JW; Sarasso S; Casarotto S; von Rotz R; Casanova A; Seifritz E; Preller KH; Tononi G; Vollenweider FX (iScience, 2023)

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review. - Fonseka LN; Woo BK (World journal of psychiatry, 2023)

Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders - Raithatha SA; Hagel JM; Matinkhoo K; Yu L; Press D; Cook SG; Sharma G; D D; Jensen G; Lee JB; Cai C; Gallant J; et al. (bioRxiv, 2023)

Characterization of Novel Tryptamines’ Anxiolytic and Anti-Inflammatory Effects in Relation to their Psychoactive Effects - Catharine Carfagno; M Vest; Kevin S. Murnane; Kariann Lamon; Bo Jarrett Wood (Journal of Pharmacology and Experimental Therapeutics, 2023)

A review of psilocybin: chemistry, clinical uses and future research directions - Eliza Milliken; Peter Galettis; Jenny Martin (Australian Journal of Chemistry, 2023)

THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE - Chirag Ambaliya; Dimple Gupta; Ashok Vala; Krupa Mukeshbhai Unadkat (PARIPEX-INDIAN JOURNAL OF RESEARCH, 2023)

A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin - University of Wisconsin; Madison (ClinicalTrials.gov, 2023)

Exposure therapy under psilocybin for general anxiety disorder and claustrophobia - THORENS G; PENZENSTADLER l; FURTADO LCDC; SERAGNOLI F; ROTHEN S; MABILAIS C; ZULLINO D. (Research Square, 2023)

Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience. - Singleton SP; Timmermann C; Luppi AI; Eckernäs E; Roseman L; Carhart-Harris RL; Kuceyeski A (bioRxiv: the preprint server for biology, 2023)

The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey. - Więckiewicz G; Marek J; Stokłosa I; Szafoni S; Pluta S; Smukowska K; Żebrowska G; Stokłosa M; Gorczyca P; Pudlo R (Medicina (Kaunas, Lithuania), 2023)

Effects of Psilocybin in Anorexia Nervosa - Johns Hopkins University (ClinicalTrials.gov, 2023)

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD. - Davis AK; Levin AW; Nagib PB; Armstrong SB; Lancelotta RL (BMJ open, 2023)

Using Psilocybin Therapy for treating end of life distress trial - Margaret Ross; Justin Dwyer (The Ballarat naturalist., 2023)

The use of classic psychedelics among adults: a Danish online survey study. - Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A (Nordic journal of psychiatry, 2023)

Unblinding and demand characteristics in the treatment of depression. - Goodwin GM; Croal M; Marwood L; Malievskaia E (Journal of affective disorders, 2023)

Trends in drug use among nightclub and festival attendees in New York City, 2017-2022. - Palamar JJ; Le A; Cleland CM; Keyes KM (The International journal on drug policy, 2023)

Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects. - Rosenblat JD; Leon-Carlyle M; Ali S; Husain MI; McIntyre RS (The American journal of psychiatry, 2023)

[Contribution of serotonin 5-HT receptor to antidepressant effect of serotonergic psychedelics]. - Ibi D (Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2023)

Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder. - Schneier FR; Feusner J; Wheaton MG; Gomez GJ; Cornejo G; Naraindas AM; Hellerstein DJ (Journal of psychiatric research, 2023)

[Drugs in the Developmental Stage (Psychotropics)]. - Uchida H (Brain and nerve = Shinkei kenkyu no shinpo, 2023)

Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis. - Bae S; Vaysblat M; Bae E; Dejanovic I; Pierce M (Cureus, 2023)

Psilocybin-Based Breakthroughs in Natural Medicine - Dunn Harmony; Freeman Judy; Michael John Dochniak (Case Reports and Reviews, 2023)

Psilocybin-based mushrooms and usage - Dunn Harmony; Freeman Judy; D Michael (Case Reports and Reviews, 2023)

Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’ - McAlpine R; Blackburne G; Kamboj S. (PsyArXiv, 2023)

Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’ - Rosalind McAlpine; George Blackburne; Sunjeev Kamboj (PsyArXiv, 2023)

A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history - Eric N. Kramer; Kalyn Reddy; Bryan Shapiro (Psychiatry Research Case Reports, 2023)

Psychedelic Sensationalism: An Analysis of the Schedule Classification of Psilocybin - Elisabeth Jean Wood (Vanderbilt Undergraduate Research Journal, 2023)

The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression - COMPASS Pathways (ClinicalTrials.gov, 2023)

A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy - Bennett JN; Blough MD; Mitchell I; Galloway L; Bains R. (medRxiv, 2023)

High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin - Braun D; Rosenberg A; Haruvi R; Malamud D; Barbara R; Kawashima T. (bioRxiv, 2023)

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. - Goodwin GM; Aaronson ST; Alvarez O; Atli M; Bennett JC; Croal M; DeBattista C; Dunlop BW; Feifel D; Hellerstein DJ; Husain MI; Kelly JR; et al. (Journal of affective disorders, 2023)

Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy–dimethyltryptamine in Mice. - Glatfelter GC; Naeem M; Pham DNK; Golen JA; Chadeayne AR; Manke DR; Baumann MH (ACS pharmacology & translational science, 2023)

118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment? - Aron Amaev; Jianmeng Song; Yasaman Kambari; Fumihiko Ueno; Edgardo Torres-Carmona; Ali Abdolizadeh; Teruki Koizumi; Vincenzo De Luca; Bruce G. Pollock; Alastair J. Flint; Muhammad Ishrat Husain; Ariel Graff-Guerrero; et al. (Biological Psychiatry, 2023)

347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder - Xi Zhu; David J. Hellerstein; Jamie D. Feusner; Michael G. Wheaton; Gloria Gómez; Franklin R. Schneier (Biological Psychiatry, 2023)

96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression - Scott Aaronson; Tammy Miller; Samuel Rudow; MacKenzie Forbes; Audrey Shoultz; Trisha Suppes (Biological Psychiatry, 2023)

Psychedelic Medicine: From Brain Science to Clinical Trials - David Nutt (Biological Psychiatry, 2023)

509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural Activity - Jonah H. Shepherd; Caitlin Baten; Amanda M. Klassen; Gladys Zamora; Sarah Saravia; Elizabeth Pritchard; Zulaikha Ali; Saneh K. Kahlon; Kyla Whitelock; Fabiola A. Reyes; Dawson H. Hedges; J. Paul Hamilton; et al. (Biological Psychiatry, 2023)

The Theoretical Description for Psilocin Electrochemical Determination over Cobalt Oxyhydroxide - Volodymyr Tkach; Kucher Mykhailo; Kushnir Marta; Ivanushko Yana; Akınay Yüksel; Karakoyun Necdet; Yagodynets Petro; Kormosh Zholt (Orbital: The Electronic Journal of Chemistry, 2023)

Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment - Jianmeng Song; Yasaman Kambari; Aron Amaev; Fumihiko Ueno; Edgardo Torres Carmona; Vincenzo De Luca; Bruce G. Pollock; Alastair J. Flint; Muhammad Ishrat Husain; Ariel Graff-Guerrero; Philip Gerretsen (Medical Hypotheses, 2023)

Psilocybin zeigt Wirkung bei Depression. - Julia Mertens L. (MMW Fortschritte der Medizin, 2023)

To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder. - Christensen JA; Fipps DC; Bostwick JM (Experimental and clinical psychopharmacology, 2023)

Microdosing psilocybin for chronic pain: a case series. - Lyes M; Yang KH; Castellanos J; Furnish T (Pain, 2023)

The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. - VanderZwaag J; Halvorson T; Dolhan K; Šimončičová E; Ben-Azu B; Tremblay MÈ (Neurochemical research, 2023)

Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants. - Holze F; Becker AM; Kolaczynska KE; Duthaler U; Liechti ME (Clinical pharmacology and therapeutics, 2023)

Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. - Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ (Neurosurgery, 2023)

Are psychedelics the answer to chronic pain: A review of current literature. - Kooijman NI; Willegers T; Reuser A; Mulleners WM; Kramers C; Vissers KCP; van der Wal SEI (Pain practice: the official journal of World Institute of Pain, 2023)

Psychedelics: Science sabotaged by Social Media. - Sellers EM; Romach MK (Neuropharmacology, 2023)

Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation. - Modlin NL; Miller TM; Rucker JJ; Kirlic N; Lennard-Jones M; Schlosser D; Aaronson ST (Journal of affective disorders, 2023)

Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. - Simonsson O; Hendricks PS; Chambers R; Osika W; Goldberg SB (Journal of affective disorders, 2023)

Liminal spaces, seasonal faces: Challenging drug market assumptions via an exploration of naturally occurring magic mushroom markets in rural Kent. - Simpson GHR; Chatwin C; van Hellemont E (The International journal on drug policy, 2023)

Systematic Review of Interventions for Demoralization in Patients With Cancer. - Wang Y; Sun H; Ji Q; Wei J; Zhu P (The Journal of nervous and mental disease, 2023)

Classic psychedelic use and current meditation practice. - Simonsson C; Chambers R; Hendricks PS; Goldberg SB; Osika W; Schlosser M; Ryde A; Christersson E; Simonsson O (Mindfulness, 2023)

Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice. - Wang K; Sun Y; Nava B; Sampiere L; Jacobs RJ (Cureus, 2023)

Psychotherapy with Psilocybin for Depression: Systematic Review. - Dawood Hristova JJ; Pérez-Jover V (Behavioral sciences (Basel, Switzerland), 2023)

Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness - University Hospital; Basel; Switzerland (ClinicalTrials.gov, 2023)

View, meditation, action: A Tibetan framework to inform psychedelic-assisted therapy - Colin H. Simonds (Journal of Psychedelic Studies, 2023)

Experts to Discuss the Ethics of Psychedelics - Terri D’Arrigo (Psychiatric News, 2023)

Default Mode Network Modulation by Psychedelics: A Systematic Review. - Gattuso JJ; Perkins D; Ruffell S; Lawrence AJ; Hoyer D; Jacobson LH; Timmermann C; Castle D; Rossell SL; Downey LA; Pagni BA; Galvão-Coelho NL; et al. (The international journal of neuropsychopharmacology, 2023)

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism. - Domanegg K; Sommer WH; Meinhardt MW (Cells, 2023)

The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience - Tolle HM; Farah JC; Mallaroni P; Mason NL; Ramaekers JG; Amico E. (bioRxiv, 2023)

Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study - Optimi Health Corporation (ClinicalTrials.gov, 2023)

Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD - Ching THW; Grazioplene R; Pittenger C; Kelmendi B. (PsyArXiv, 2023)

Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD - Terence Ching; Rachael Grazioplene; Christopher Pittenger; Benjamin Kelmendi (PsyArXiv, 2023)

The varieties of psychedelic law. - Marks M (Neuropharmacology, 2023)

Canalization and plasticity in psychopathology. - Carhart-Harris RL; Chandaria S; Erritzoe DE; Gazzaley A; Girn M; Kettner H; Mediano PAM; Nutt DJ; Rosas FE; Roseman L; Timmermann C; Weiss B; et al. (Neuropharmacology, 2023)

Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health. - Ryan RS; Copello A; Fox AP (BMC psychiatry, 2023)

The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice. - Zanikov T; Gerasymchuk M; Ghasemi Gojani E; Robinson GI; Asghari S; Groves A; Haselhorst L; Nandakumar S; Stahl C; Cameron M; Li D; Rodriguez-Juarez R; et al. (Molecules (Basel, Switzerland), 2023)

Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder - New York State Psychiatric Institute (ClinicalTrials.gov, 2023)

Patternizing Psilocybin in Logic Space - Parker Emmerson (Zenodo (CERN European Organization for Nuclear Research), 2023)

Understanding psychedelic 'mystical experience'-A case example - Turkia M. (PsyArXiv, 2023)

Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study - Turkia M. (PsyArXiv, 2023)

Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study - Turkia M. (PsyArXiv, 2023)

Understanding psychedelic 'mystical experience'-A case example - Mika Turkia (PsyArXiv, 2023)

Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study - Mika Turkia (PsyArXiv, 2023)

Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study - Mika Turkia (PsyArXiv, 2023)

Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness? - Steven W. Cotten; Frederick G. Strathmann; Frederick S. Barrett; Laura Labay; James Mullally; Alexander M. Sherwood; Frank Wiegand (Clinical Chemistry, 2023)

Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles. - Kalkman HO (Biomedicines, 2023)

How psychedelics spark neuronal growth - Shi En Kim (C&EN Global Enterprise, 2023)

Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training? - Emmerich N; Humphries B (Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees, 2023)

Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review. - Lazur J; Hnatyk K; Kała K; Sułkowska-Ziaja K; Muszyńska B (Antioxidants (Basel, Switzerland), 2023)

A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression. - Nayak SM; Bari BA; Yaden DB; Spriggs MJ; Rosas FE; Peill JM; Giribaldi B; Erritzoe D; Nutt DJ; Carhart-Harris R (Psychedelic medicine (New Rochelle, N.Y.), 2023)

A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders. - Kisely S; Connor M; Somogyi AA; Siskind D (The Australian and New Zealand journal of psychiatry, 2023)

[Attitudes of Mental Health Experts Towards Psilocybin]. - Schmidt C; Wolff M; Gründer G; Jungaberle H (Fortschritte der Neurologie-Psychiatrie, 2023)

Update on treatments for anxiety-related disorders. - Lee HJ; Stein MB (Current opinion in psychiatry, 2023)

Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines. - Heal DJ; Gosden J; Smith SL; Atterwill CK (Neuropharmacology, 2023)

Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded. - Otterman LS (Journal of bioethical inquiry, 2023)

Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway. - McTaggart AR; James TY; Slot JC; Barlow C; Fechner N; Shuey LS; Drenth A (Fungal genetics and biology: FG & B, 2023)

Interaction of psychedelic tryptamine derivatives with a lipid bilayer. - Zohairi F; Khandelia H; Hakami Zanjani AA (Chemistry and physics of lipids, 2023)

Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling - Wang Jing; Liang Min; Shang Qing; Qian Hongyan; An Ran; Liu Hua; Shao Gaojie; Li Tao; Liu Xinshe (CNS Neuroscience & Therapeutics, 2023)

Utility of preclinical models in the study of psilocybin - A comprehensive review. - Pedicini M; Cordner ZA (Neuroscience and biobehavioral reviews, 2023)

Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs. - Oster E; Čudina N; Pavasović H; Prevendar Crnić A; Božić F; Fadel C; Giorgi M (Veterinary and animal science, 2023)

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape. - Jha MK; Mathew SJ (The American journal of psychiatry, 2023)

[Psychedelic Therapy with Psilocybin and Psychotherapy - Where do we Stand?]. - Karow A (Psychotherapie, Psychosomatik, medizinische Psychologie, 2023)

A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression. - Hibicke M; Kramer HM; Nichols CD (Psychedelic medicine (New Rochelle, N.Y.), 2023)

Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice. - Aday JS; Skiles Z; Eaton N; Fredenburg L; Pleet M; Mantia J; Bradley ER; Fernandes-Osterhold G; Woolley JD (Psychedelic medicine (New Rochelle, N.Y.), 2023)

The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies - J. H. Shepherd; C.T.M. Baten; A. C. Klassen; G. Zamora; Sarah Saravia; Elizabeth Pritchard; Ziad A. Ali; S. K. Kahlon; Kyla Whitelock; F. A. Reyes; D. W. Hedges; J. Paul Hamilton; et al. (European Psychiatry, 2023)

Effect of psilocybin on decision-making and motivation in the healthy rat. - Roberts BF; Zylko AL; Waters CE; Crowder JD; Gibbons WJ; Sen AK; Jones JA; McMurray MS (Behavioural brain research, 2023)

Psilocybin for Treatment-Resistant Depression. - Østergaard SD; Hieronymus F (The New England journal of medicine, 2023)

UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice. - Rijsketic DR; Casey AB; Barbosa DAN; Zhang X; Hietamies TM; Ramirez-Ovalle G; Pomrenze M; Halpern CH; Williams LM; Malenka RC; Heifets BD (bioRxiv: the preprint server for biology, 2023)

Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First - Jacques Ambrose; J.S. Zabinski (Psychiatric News, 2023)

Psychedelics Legislation Gains Momentum - Terri D’Arrigo (Psychiatric News, 2023)